Placebo response variability on health-related quality of life outcomes in irritable bowel syndrome: an arm-based network meta-analysis.

Researchers examined how different types of "placebo" or "sham" treatments affect quality of life in people with irritable bowel syndrome (IBS). This large study analyzed 45 clinical trials involving over 5,000 IBS patients to understand which placebo methods produced the greatest improvements in symptoms and quality of life. The researchers looked at three main outcomes: IBS symptom severity scores, quality of life measures, and symptom intensity using visual scales. The findings showed that sham moxibustion (a traditional Chinese medicine technique involving heat near acupuncture points, but delivered in a non-therapeutic way) produced the most significant reduction in IBS symptom severity scores. Sham fecal microbiota transplant showed the greatest improvement in quality of life scores, while placebo tablets were most effective at reducing symptom intensity on visual scales. What does this mean for patients considering acupuncture-related treatments? This study highlights that even "fake" versions of moxibustion can provide meaningful symptom relief in IBS, suggesting powerful mind-body effects. However, the researchers noted that the evidence quality for moxibustion was lower compared to other interventions studied. The placebo effect is an important consideration in IBS management, as this condition is known to be particularly responsive to the therapeutic relationship and patient expectations. Understanding these effects helps both patients and practitioners make informed decisions about treatment approaches. If you're considering acupuncture or moxibustion for IBS, consult with a licensed acupuncturist who is nationally certified and experienced in treating digestive disorders.

This arm-based Bayesian network meta-analysis examined placebo response variability across 45 randomized, double-blind, placebo-controlled trials involving 5,174 IBS patients. Primary outcome was IBS-Severity Scoring System (IBS-SSS), with secondary outcomes including IBS-QoL and VAS scores. The analysis compared various placebo modalities including sham moxibustion, sham FMT, and placebo tablets. Results demonstrated sham moxibustion produced the largest effect on IBS-SSS reduction (MD -260.00, 95% CrIs: -288.00 to -232.00), while sham FMT showed greatest improvement in IBS-QoL scores (MD 9.23, 95% CrIs: -3.69 to 22.30). Placebo tablets were most effective for VAS score reduction (MD 4.71, 95% CrIs: -1.14 to 11.10). However, GRADE assessment indicated evidence quality for sham moxibustion was less robust than other interventions. Clinical implications include recognition of substantial placebo effects in IBS, particularly with traditional medicine modalities, which should inform treatment design and patient counseling regarding expected therapeutic responses.